The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2008

Filed:

Sep. 20, 2004
Applicants:

Christopher R. Tudan, Vancouver, CA;

Ahmed Merzouk, Richmond, CA;

Lakhdar Arab, Vancouver, CA;

Geeta Saxena, Vancouver, CA;

Connie J. Eaves, Vancouver, CA;

Johanne Cashman, Vancouver, CA;

Mary A. Richter, Legal Representative, Vancouver, CA;

Michael Clark-lewis, Legal Representative, Northbridge, AU;

Hassan Salari, Delta, CA;

Inventors:

Christopher R. Tudan, Vancouver, CA;

Ahmed Merzouk, Richmond, CA;

Lakhdar Arab, Vancouver, CA;

Geeta Saxena, Vancouver, CA;

Connie J. Eaves, Vancouver, CA;

Johanne Cashman, Vancouver, CA;

Mary A. Richter, legal representative, Vancouver, CA;

Michael Clark-Lewis, legal representative, Northbridge, AU;

Hassan Salari, Delta, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61K 38/10 (2006.01); A61K 38/07 (2006.01); C07K 2/00 (2006.01); C07K 14/00 (2006.01); C07K 7/08 (2006.01); C07K 5/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.


Find Patent Forward Citations

Loading…